Welcome to This Week in Dermatology. This week we are covering seven notable papers spanning novel oral therapeutics for psoriasis, hair loss interventions, and complex dermatopathological entities. Let's dive in. [PAUSE] We begin with a major development in the management of moderate-to-severe plaque psoriasis. In the British Journal of Dermatology, researchers shared the one-year results from t…

This week's papers:

Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials. — The British journal of dermatology 2026
Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study. — Journal of the American Academy of Dermatology 2026
Safety of Biologic Therapy in Psoriasis Patients With Malignancy. — Journal of the American Academy of Dermatology 2026
Comparative Alopecia Outcomes After Copper and Hormonal Intrauterine Device Placement: A TriNetX Database Retrospective Cohort Study. — Journal of the American Academy of Dermatology 2026
Microneedling with adipose MSC exosomes versus monotherapy for androgenetic alopecia. — Journal of the European Academy of Dermatology and Venereology : JEADV 2026
Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients. — The British journal of dermatology 2026
Genomic Predictors of Perineural Invasion in Cutaneous Squamous Cell Carcinoma: Insights from an MD Anderson Cohort. — Journal of the American Academy of Dermatology 2026